NASDAQ:ICCM

IceCure Medical - ICCM Stock Forecast, Price & News

$1.10

+0.01 (+0.91%)

(As of 03/23/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.09
▼
$1.13
50-Day Range: $1.05
▼
$1.49
52-Week Range: $0.75
▼
$4.73

Volume: 60,623 shs
Average Volume: 279,456 shs
Market Capitalization: $50.41 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $4.38

Institutional Ownership

IceCure Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 295.9% Upside
$4.38 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: -0.09
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.44) to ($0.33) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

851st out of 986 stocks

Surgical & Medical Instruments Industry

86th out of 100 stocks

3.5

Analyst's Opinion

Consensus Rating
IceCure Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $4.38, IceCure Medical has a forecasted upside of 295.9% from its current price of $1.11.
Amount of Analyst Coverage
IceCure Medical has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for ICCM.

0.0

Dividend Strength

Dividend Yield
IceCure Medical does not currently pay a dividend.
Dividend Growth
IceCure Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ICCM.

1.6

News and Social Media Coverage

News Sentiment
IceCure Medical has a news sentiment score of -0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for IceCure Medical this week, compared to 1 article on an average week.
Search Interest
10 people have searched for ICCM on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, IceCure Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 2.44% of the stock of IceCure Medical is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for IceCure Medical are expected to grow in the coming year, from ($0.44) to ($0.33) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of IceCure Medical is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of IceCure Medical is -2.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About IceCure Medical (NASDAQ:ICCM) Stock

IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Stock News Headlines

March 22, 2023 | americanbankingnews.com

HC Wainwright Initiates Coverage on IceCure Medical (NASDAQ:ICCM)

March 20, 2023 | finance.yahoo.com

IceCure Medical to Report 2022 Full Year Financial & Operational Results on March 29, 2023

March 23, 2023 | Weiss Ratings (Ad)

Fed's Shocking New Plan to Control Your Money

The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 

March 17, 2023 | finance.yahoo.com

7 Speculative Penny Stocks to Bet On This March

February 9, 2023 | finance.yahoo.com

IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational Highlights

January 26, 2023 | finance.yahoo.com

IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.

January 25, 2023 | finance.yahoo.com

IceCure's ProSense Presented in Hands-On Training Course at The American Society of Breast Surgeons Breast Follows Ultrasound Course

January 24, 2023 | seekingalpha.com

ICCM IceCure Medical Ltd

March 23, 2023 | Weiss Ratings (Ad)

Fed's Shocking New Plan to Control Your Money

January 23, 2023 | finance.yahoo.com

U.S. Patent Office Grants Notice of Allowance to IceCure for Novel Cryogenic Pump for Next-Generation Cryoablation Systems

January 18, 2023 | finance.yahoo.com

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems

December 23, 2022 | finance.yahoo.com

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

December 21, 2022 | finance.yahoo.com

IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

December 20, 2022 | finance.yahoo.com

IceCure Medical Ltd. Announces Proposed Public Offering

December 20, 2022 | proactiveinvestors.com

IceCure Medical rockets higher on positive study data showing effectiveness of ProSense kidney tumor treatment

December 20, 2022 | benzinga.com

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

December 19, 2022 | nasdaq.com

1,000% Move in a Day: Medical Stock Soars on Positive Data

December 19, 2022 | finance.yahoo.com

IceCure's ProSense Safe and Effective in Treating Kidney Tumors with 89.5% Recurrence-Free Rate Based on Interim Study Results

December 19, 2022 | benzinga.com

IceCure Medical Stock Is On Fire After Hours: What's Going On?

December 8, 2022 | finance.yahoo.com

IceCure Medical Ltd (NASDAQ:ICCM) Q3 2022 Earnings Call Transcript

December 6, 2022 | finance.yahoo.com

IceCure Appoints Vincent Chun Hung Chan to Serve as an Independent Director on its Board of Directors

December 5, 2022 | seekingalpha.com

IceCure Medical Ltd (ICCM) Q3 2022 Earnings Call Transcript

December 5, 2022 | finance.yahoo.com

IceCure Medical Reports Financial Results for the Nine Months Ended September 30, 2022 and Provides Update on Recent Operational Highlights

November 30, 2022 | finance.yahoo.com

IceCure's ProSense Featured in Poster Presentation at Radiological Society of North America's 2022 Annual Meeting

November 29, 2022 | finance.yahoo.com

TIME CHANGE: IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

November 28, 2022 | finance.yahoo.com

IceCure Medical to Report Financial Results for the 9-Month Period Ended September 30, 2022 and Conduct Conference Call on December 5, 2022

November 8, 2022 | investorplace.com

What Is Going on With IceCure Medical (ICCM) Stock Today?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Company Calendar

Today: 3/23/2023
Next Earnings (Confirmed): 3/29/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ICCM
CUSIP: N/A
CIK: 1584371
Web: www.icecure-medical.com
Phone: 972-4623-0333
Fax: 972-4623-0222
Employees: 40
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $4.38
High Stock Price Forecast: $5.75
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +294.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.45)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,900,000.00
Net Margins: -462.46%
Pretax Margin: N/A
Return on Equity: -77.00%
Return on Assets: -61.72%

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 4.22
Quick Ratio: 3.58

Sales & Book Value

Annual Sales: $4.14 million
Price / Sales: 12.23
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 45,620,000
Free Float: 44,510,000
Market Cap: $50.64 million
Optionable: Not Optionable
Beta: -0.25

Key Executives

Mr. Eyal Shamir (Age 62)
CEO & Director
Comp: $426k

Mr. Ronen Tsimerman CPA (Age 54)
CFO & COO
Comp: $324k

Ms. Tlalit Bussi Tel-Tzure (Age 52)
VP of Bus. Devel. & Global Marketing
Comp: $249k

Ms. Merav Nir Dotan (Age 54)
VP of HR
Comp: $32k

Mr. Naum Muchnik (Age 47)
VP of Research, Devel. & Engineering
Comp: $238k

Mr. Shay Levav (Age 46)
VP of Regulatory and Quality Assurance & Clinical Applications
Comp: $239k

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ICCM Stock - Frequently Asked Questions

Should I buy or sell IceCure Medical stock right now?: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IceCure Medical in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICCM shares.
View ICCM analyst ratings or view top-rated stocks.
What is IceCure Medical's stock price forecast for 2023?: 3 equities research analysts have issued twelve-month price targets for IceCure Medical's stock. Their ICCM share price forecasts range from $3.00 to $5.75. On average, they predict the company's share price to reach $4.38 in the next twelve months. This suggests a possible upside of 294.1% from the stock's current price.
View analysts price targets for ICCM or view top-rated stocks among Wall Street analysts.
How have ICCM shares performed in 2023?: IceCure Medical's stock was trading at $1.55 at the start of the year. Since then, ICCM stock has decreased by 28.4% and is now trading at $1.11.
View the best growth stocks for 2023 here.
When is IceCure Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 29th 2023.
View our ICCM earnings forecast.
How can I listen to IceCure Medical's earnings call?: IceCure Medical will be holding an earnings conference call on Wednesday, March 29th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.
What guidance has IceCure Medical issued on next quarter's earnings?: IceCure Medical updated its FY 2022 earnings guidance on Thursday, February, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.10 million-$3.10 million, compared to the consensus revenue estimate of $3.59 million.

What is IceCure Medical's stock symbol?: IceCure Medical trades on the NASDAQ under the ticker symbol "ICCM."
Who are IceCure Medical's major shareholders?: IceCure Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include Bank of America Corp DE (0.12%), Boothbay Fund Management LLC (0.09%) and UBS Group AG (0.06%).
How do I buy shares of IceCure Medical?: Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is IceCure Medical's stock price today?: One share of ICCM stock can currently be purchased for approximately $1.11.
How much money does IceCure Medical make?: IceCure Medical (NASDAQ:ICCM) has a market capitalization of $50.64 million and generates $4.14 million in revenue each year. The company earns $-9,900,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.
How can I contact IceCure Medical?: The official website for the company is www.icecure-medical.com. The company can be reached via phone at 972-4623-0333, via email at jeremy@lifesciadvisors.com, or via fax at 972-4623-0222.

This page (NASDAQ:ICCM) was last updated on 3/23/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

IceCure Medical - ICCM Stock Forecast, Price & News

IceCure Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

Company Ownership

Earnings and Valuation

About IceCure Medical (NASDAQ:ICCM) Stock

ICCM Stock News Headlines

ICCM Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

ICCM Stock - Frequently Asked Questions

Overall MarketRank^™